Cover Image
市場調查報告書

運動醫學的局部疼痛管理治療藥市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測(2017年∼2025年)

Topical Pain Management Therapeutics in Sports Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 606146
出版日期 內容資訊 英文 200 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
運動醫學的局部疼痛管理治療藥市場 - 產業分析,市場規模,佔有率,成長,趨勢,預測(2017年∼2025年) Topical Pain Management Therapeutics in Sports Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2018年01月22日 內容資訊: 英文 200 Pages
簡介

本報告提供運動醫學的局部疼痛管理治療藥市場相關調查,市場概要,各產品形態、治療藥級、地區的市場趨勢,市場規模的變化與預測,市場成長、阻礙因素以及市場機會分析,市場佔有率,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查的重點

第2章 前提和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
    • 產品定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 市場分析與預測
  • 波特的五力分析
  • 市場預測
  • WHO方式的疼痛治療方法
  • 貼片設計技術概要
  • 治療藥概要:醫療用醫藥品、一般用類醫藥品

第5章 運動醫學的局部疼痛管理治療藥市場分析與預測:各產品形態

  • 簡介
  • 主要的發現/開發
  • 市場規模的變化與預測:各產品形態
    • 凝膠
    • 噴霧
    • 貼片
  • 各市場魅力分析:各產品形態

第6章 運動醫學的局部疼痛管理治療藥市場分析與預測:各治療藥分級

  • 簡介
  • 主要的發現/開發
  • 市場規模的變化與預測、各治療藥分級
    • 止痛藥
    • 麻醉劑
    • 肌肉鬆弛劑
  • 市場魅力分析:各治療藥分級

第7章 運動醫學的局部疼痛管理治療藥市場分析與預測:各地區

  • 主要的觀察
  • 市場規模的變化與預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力分析:各地區

第8章 北美

第9章 歐洲

第10章 亞太地區

第11章 南美

第12章 中東、非洲

第13章 競爭情形

  • 參與企業的競爭分析(各等級及市場規模)
  • 企業的市場佔有率分析
  • 企業簡介(詳細內容 - 概要,財務,最新趨勢,策略)
    • Beiersdorf AG
    • Endo Pharmaceuticals Inc.
    • GlaxoSmithKline plc.
    • 久光製藥
    • Johnson & Johnson Services, Inc.
    • Mayne Pharma Group Limited
    • Pfizer Inc.
    • Sanofi (Chattem, Inc. )
    • Teva Pharmaceutical Industries Limited
    • Topical BioMedics, Inc.
目錄

Title:
Topical Pain Management Therapeutics in Sports Medicine Market (Product - Gels, Cream, Sprays, and Patches (Drug in Adhesive, Matrix, and Reservoirs); Therapeutic Class - Analgesics (Opioids, Non-opioids), Anesthetics, and Skeletal Muscle Relaxants) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Topical Pain Management Therapeutics in Sports Medicine Market: Scope and Methodology

This report on the global topical pain management therapeutics in sports medicine market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment and sub-segment for the period from 2017 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global topical pain management therapeutics in sports medicine market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global topical pain management therapeutics in sports medicine Market.

Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of product features of different types of products. Additionally, market related factors such as rise in preference for topical therapeutics, rising sports injuries, projected launch of the products etc. in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Topical Pain Management Therapeutics in Sports Medicine Market: Segmentation

Topical pain management therapeutics are specialty products that are used to relieve acute musculoskeletal pain or general sprains or strains. The therapeutics involve various drug classes such as analgesics, anesthetics, and skeletal muscle relaxants.

Based on product, the global topical pain management therapeutics in sports medicine market has been segmented into gels, cream, sprays and patches. The patches segment is further segmented into drugs in adhesives, matrix, reservoirs and others. The gel segment is anticipated to hold a significant share of the global market. The segment is projected to dominate the market during the forecast period due to the local players offering cost effective novel gel formulation.

Based on therapeutic class, the global topical pain management therapeutics in sports medicine market is segmented into analgesics, anesthetics and skeletal muscle relaxants. The analgesics segment is further divided into opioids and non-opioids. The opioids are further classified into fentanyl, buprenorphine and others, while the no-opioids are further segmented into lidocaine, diclofenac, capsaicin, methyl salicylate and others. The analgesics segment is anticipated to dominate the global market throughout the forecast period owing to shift of patient preference from oral drugs to topical analgesics.

Topical Pain Management Therapeutics in Sports Medicine Market: Geographical and Competitive Dynamics

Geographically, the global topical pain management therapeutics in sports medicine market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region.

The report also profiles major players in the topical pain management therapeutics in sports medicine market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Hisamitsu Pharmaceutical Co., Inc., Mayne Pharma Group Limited, Sanofi (Chattem, Inc.), GlaxoSmithKline plc, Endo Pharmaceuticals Inc., Beiersdorf AG, Johnson & Johnson Services, Inc., and Topical BioMedics, Inc.

The global topical pain management therapeutics in sports medicine market has been segmented as follows:

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Product

  • Gels
  • Creams
  • Sprays
  • Patches
  • Drug in Adhesives
  • Matrix
  • Reservoirs
  • Others

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Therapeutic Class

  • Analgesics
    • Opioids
    • Fentanyl
    • Buprenorphine
    • Others
  • Non-opioids
    • Lidocaine
    • Diclofenac
    • Capsaicin
    • Methyl Salicylate
    • Others
  • Anesthetics
  • Skeletal Muscle Relaxants

Global Topical Pain Management Therapeutics in Sports Medicine Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Topical Pain Management Therapeutics in Sports Medicine Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Increasing incidence of musculoskeletal acute sports injuries.
      • 4.3.1.2. Guidelines implemented by various healthcare organizations promoting use of topical medications over oral medications in pain management
      • 4.3.1.3. Innovative product launches, such as fast-relief liquid gel formulations, by market players leading to growing demand
    • 4.3.2. Restraints
      • 4.3.2.1. Growing patient preference for pain management devices in treatment of sports injuries
    • 4.3.3. Opportunity
  • 4.4. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, 2015-2025
  • 4.5. Porter's Five Force Analysis
  • 4.6. Market Outlook
  • 4.7. WHO Pain Relief Ladder
  • 4.8. Patch Design Technologies: Snapshot
  • 4.9. Snapshot: Topical Pain Management Therapeutics in Sport Industry - by Prescription and OTC products; 2016

5. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Market Value Forecast By Product, 2015-2025
    • 5.3.1. Gel
    • 5.3.2. Creams
    • 5.3.3. Sprays
    • 5.3.4. Patches
      • 5.3.4.1. Drug in Adhesives
      • 5.3.4.2. Matrix
      • 5.3.4.3. Reservoirs
      • 5.3.4.4. Others
  • 5.4. Market Attractiveness By Product

6. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Therapeutic Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 6.3.1. Analgesics
      • 6.3.1.1. Opioids
        • 6.3.1.1.1. Fentanyl
        • 6.3.1.1.2. Buprenorphine
        • 6.3.1.1.3. Others
      • 6.3.1.2. Non-opioids
        • 6.3.1.2.1. Lidocaine
        • 6.3.1.2.2. Diclofenac
        • 6.3.1.2.3. Capsaicin
        • 6.3.1.2.4. Methyl Salicylate
        • 6.3.1.2.5. Others
    • 6.3.2. Anesthetics
    • 6.3.3. Skeletal Muscle Relaxants
  • 6.4. Market Attractiveness By Therapeutic Class

7. Global Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecasts, By Region

  • 7.1. Key Findings
  • 7.2. Market Value Forecast By Region
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. Market Attractiveness By Region

8. North America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
  • 8.2. Market Value Forecast By Product, 2015-2025
    • 8.2.1. Gel
    • 8.2.2. Creams
    • 8.2.3. Sprays
    • 8.2.4. Patches
      • 8.2.4.1. Drug in Adhesives
      • 8.2.4.2. Matrix
      • 8.2.4.3. Reservoirs
      • 8.2.4.4. Others
  • 8.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 8.3.1. Analgesics
      • 8.3.1.1. Opioids
        • 8.3.1.1.1. Fentanyl
        • 8.3.1.1.2. Buprenorphine
        • 8.3.1.1.3. Others
      • 8.3.1.2. Non-opioids
        • 8.3.1.2.1. Lidocaine
        • 8.3.1.2.2. Diclofenac
        • 8.3.1.2.3. Capsaicin
        • 8.3.1.2.4. Methyl Salicylate
        • 8.3.1.2.5. Others
    • 8.3.2. Anesthetics
    • 8.3.3. Skeletal Muscle Relaxants
  • 8.4. Market Value Forecast By Country, 2015-2025
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By Therapeutic Class
    • 8.5.3. By Country

9. Europe Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast By Product, 2015-2025
    • 9.2.1. Gel
    • 9.2.2. Creams
    • 9.2.3. Sprays
    • 9.2.4. Patches
      • 9.2.4.1. Drug in Adhesives
      • 9.2.4.2. Matrix
      • 9.2.4.3. Reservoirs
      • 9.2.4.4. Others
  • 9.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 9.3.1. Analgesics
      • 9.3.1.1. Opioids
        • 9.3.1.1.1. Fentanyl
        • 9.3.1.1.2. Buprenorphine
        • 9.3.1.1.3. Others
      • 9.3.1.2. Non-opioids
        • 9.3.1.2.1. Lidocaine
        • 9.3.1.2.2. Diclofenac
        • 9.3.1.2.3. Capsaicin
        • 9.3.1.2.4. Methyl Salicylate
        • 9.3.1.2.5. Others
    • 9.3.2. Anesthetics
    • 9.3.3. Skeletal Muscle Relaxants
  • 9.4. Market Value Forecast By Country / Sub-region, 2015-2025
    • 9.4.1. Germany
    • 9.4.2. U.K.
    • 9.4.3. France
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Therapeutic Class
    • 9.5.3. By Country / Sub-region

10. Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product, 2015-2025
    • 10.2.1. Gel
    • 10.2.2. Creams
    • 10.2.3. Sprays
    • 10.2.4. Patches
      • 10.2.4.1. Drug in Adhesives
      • 10.2.4.2. Matrix
      • 10.2.4.3. Reservoirs
      • 10.2.4.4. Others
  • 10.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 10.3.1. Analgesics
      • 10.3.1.1. Opioids
        • 10.3.1.1.1. Fentanyl
        • 10.3.1.1.2. Buprenorphine
        • 10.3.1.1.3. Others
      • 10.3.1.2. Non-opioids
        • 10.3.1.2.1. Lidocaine
        • 10.3.1.2.2. Diclofenac
        • 10.3.1.2.3. Capsaicin
        • 10.3.1.2.4. Methyl Salicylate
        • 10.3.1.2.5. Others
    • 10.3.2. Anesthetics
    • 10.3.3. Skeletal Muscle Relaxants
  • 10.4. Market Value Forecast By Country / Sub-region, 2015-2025
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Therapeutic Class
    • 10.5.3. By Country / Sub-region

11. Latin America Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2015-2025
    • 11.2.1. Gel
    • 11.2.2. Creams
    • 11.2.3. Sprays
    • 11.2.4. Patches
      • 11.2.4.1. Drug in Adhesives
      • 11.2.4.2. Matrix
      • 11.2.4.3. Reservoirs
      • 11.2.4.4. Others
  • 11.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 11.3.1. Analgesics
      • 11.3.1.1. Opioids
        • 11.3.1.1.1. Fentanyl
        • 11.3.1.1.2. Buprenorphine
        • 11.3.1.1.3. Others
      • 11.3.1.2. Non-opioids
        • 11.3.1.2.1. Lidocaine
        • 11.3.1.2.2. Diclofenac
        • 11.3.1.2.3. Capsaicin
        • 11.3.1.2.4. Methyl Salicylate
        • 11.3.1.2.5. Others
    • 11.3.2. Anesthetics
    • 11.3.3. Skeletal Muscle Relaxants
  • 11.4. Market Value Forecast By Country / Sub-region, 2015-2025
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Therapeutic Class
    • 11.5.3. By Country / Sub-region

12. Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2015-2025
    • 12.2.1. Gel
    • 12.2.2. Creams
    • 12.2.3. Sprays
    • 12.2.4. Patches
      • 12.2.4.1. Drug in Adhesives
      • 12.2.4.2. Matrix
      • 12.2.4.3. Reservoirs
      • 12.2.4.4. Others
  • 12.3. Market Value Forecast By Therapeutic Class, 2015-2025
    • 12.3.1. Analgesics
      • 12.3.1.1. Opioids
        • 12.3.1.1.1. Fentanyl
        • 12.3.1.1.2. Buprenorphine
        • 12.3.1.1.3. Others
      • 12.3.1.2. Non-opioids
        • 12.3.1.2.1. Lidocaine
        • 12.3.1.2.2. Diclofenac
        • 12.3.1.2.3. Capsaicin
        • 12.3.1.2.4. Methyl Salicylate
        • 12.3.1.2.5. Others
    • 12.3.2. Anesthetics
    • 12.3.3. Skeletal Muscle Relaxants
  • 12.4. Market Value Forecast By Country / Sub-region, 2015-2025
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East & Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Therapeutic Class
    • 12.5.3. By Country / Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 13.2. Market Share Analysis By Company (2016)
  • 13.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 13.3.1. Beiersdorf AG
      • 13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.1.2. Product Portfolio
      • 13.3.1.3. SWOT Analysis
      • 13.3.1.4. Financial Overview
      • 13.3.1.5. Strategic Overview
    • 13.3.2. Endo Pharmaceuticals Inc.
      • 13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.2.2. Product Portfolio
      • 13.3.2.3. SWOT Analysis
      • 13.3.2.4. Financial Overview
      • 13.3.2.5. Strategic Overview
    • 13.3.3. GlaxoSmithKline plc.
      • 13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.3.2. Product Portfolio
      • 13.3.3.3. SWOT Analysis
      • 13.3.3.4. Financial Overview
      • 13.3.3.5. Strategic Overview
    • 13.3.4. Hisamitsu Pharmaceutical Co.,Inc.
      • 13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.4.2. Product Portfolio
      • 13.3.4.3. SWOT Analysis
      • 13.3.4.4. Financial Overview
      • 13.3.4.5. Strategic Overview
    • 13.3.5. Johnson & Johnson Services, Inc.
      • 13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.5.2. Product Portfolio
      • 13.3.5.3. SWOT Analysis
      • 13.3.5.4. Financial Overview
      • 13.3.5.5. Strategic Overview
    • 13.3.6. Mayne Pharma Group Limited
      • 13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.6.2. Product Portfolio
      • 13.3.6.3. SWOT Analysis
      • 13.3.6.4. Financial Overview
      • 13.3.6.5. Strategic Overview
    • 13.3.7. Pfizer Inc.
      • 13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.7.2. Product Portfolio
      • 13.3.7.3. SWOT Analysis
      • 13.3.7.4. Financial Overview
      • 13.3.7.5. Strategic Overview
    • 13.3.8. Sanofi (Chattem, Inc. )
      • 13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.8.2. Product Portfolio
      • 13.3.8.3. SWOT Analysis
      • 13.3.8.4. Financial Overview
      • 13.3.8.5. Strategic Overview
    • 13.3.9. Teva Pharmaceutical Industries Limited
      • 13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.9.2. Product Portfolio
      • 13.3.9.3. SWOT Analysis
      • 13.3.9.4. Financial Overview
      • 13.3.9.5. Strategic Overview
    • 13.3.10. Topical BioMedics, Inc.
      • 13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 13.3.10.2. Product Portfolio
      • 13.3.10.3. SWOT Analysis
      • 13.3.10.4. Financial Overview
      • 13.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025
  • Table 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Region, 2015-2025
  • Table 08: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 09: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 10: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 11: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 12: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 13: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 14: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025
  • Table 15: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 16: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 17: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 18: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 19: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 20: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 21: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025
  • Table 22: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 23: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 24: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 25: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 26: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 27: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 28: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025
  • Table 29: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 30: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 31: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 32: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 33: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 34: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 35: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025
  • Table 36: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Country, 2015-2025
  • Table 37: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Product, 2015-2025
  • Table 38: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Patches, 2015-2025
  • Table 39: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Therapeutic Class, 2015-2025
  • Table 40: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Analgesic Therapeutic Class, 2015-2025
  • Table 41: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Opioid Analgesic Therapeutic Class, 2015-2025
  • Table 42: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast, by Non-opioid Analgesic Therapeutic Class, 2015-2025

List of Figures

  • Figure 01: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn), CAGR and Share (%), by Geography, 2017 and 2025
  • Figure 02: Global Topical Pain Management Therapeutics in Sports Medicine Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 03: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product (2016)
  • Figure 04: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class (2016)
  • Figure 05: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region (2016)
  • Figure 06: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 07: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gels, 2015-2025
  • Figure 08: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Creams, 2015-2025
  • Figure 09: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Sprays, 2015-2025
  • Figure 10: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Patches, 2015-2025
  • Figure 11: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017-2025
  • Figure 12: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class , 2017 and 2025
  • Figure 13: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Analgesics, 2015-2025
  • Figure 14: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anesthetics, 2015-2025
  • Figure 15: Global Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skeletal Muscle Relaxants, 2015-2025
  • Figure 16: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017-2025
  • Figure 17: Global Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Region, 2017 and 2025
  • Figure 18: Global Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Region, 2017-2025
  • Figure 19: North America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 20: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2017 and 2025
  • Figure 21: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017-2025
  • Figure 22: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 23: North America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2017 and 2025
  • Figure 24: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017 and 2025
  • Figure 25: North America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017-2025
  • Figure 26: Europe Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 27: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2017 and 2025
  • Figure 28: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017-2025
  • Figure 29: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 30: Europe Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2017 and 2025
  • Figure 31: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017 and 2025
  • Figure 32: Europe Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017-2025
  • Figure 33: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 34: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2017 and 2025
  • Figure 35: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017-2025
  • Figure 36: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 37: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2017 and 2025
  • Figure 38: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017 and 2025
  • Figure 39: Asia Pacific Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017-2025
  • Figure 40: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2015-2025
  • Figure 41: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2017 and 2025
  • Figure 42: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017-2025
  • Figure 43: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 44: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2017 and 2025
  • Figure 45: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017 and 2025
  • Figure 46: Latin America Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017-2025
  • Figure 47: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 48: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Country, 2017 and 2025
  • Figure 49: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Country, 2017-2025
  • Figure 50: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Product, 2017 and 2025
  • Figure 51: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Value Share, by Therapeutic Class, 2017 and 2025
  • Figure 52: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Product, 2017 and 2025
  • Figure 53: Middle East & Africa Topical Pain Management Therapeutics in Sports Medicine Market Attractiveness, by Therapeutic Class, 2017-2025
  • Figure 54: Global Topical Pain Management Therapeutics in Sports Medicine Market Share (%) & Market Share Range (%), by Company, 2016
  • Figure 55: Teva Pharmaceutical Industries Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 56: Teva Pharmaceutical Industries Ltd., Breakdown of Net Sales (%), by Business Segment, 2016
  • Figure 57: Pfizer, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 58: Pfizer, Inc., Breakdown of Net Sales (%), by Business Segment, 2016
  • Figure 59: Hisamitsu Pharmaceutical Co.,Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013-2016
  • Figure 60: Hisamitsu Pharmaceutical Co. Inc., Breakdown of Net Sales (%), by Region, 2016
Back to Top